Medicovestor, Inc.
Antibody-drug conjugate (ADC) platform with dual-antibody technology for cancer immunotherapy
- Sector
- Biotech
- Headquarters
- NEW YORK, NY
- Latest Form D
- $3.2M, Dec 2025
- Total capital
- $3.2M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $3.2M
- 1 Form D · last Dec 2025
- 11 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 13
- 21 pending · first 2024
- Rank in peer group#131 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$3.2M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#131 · top 9%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Seah Hooi LimResearcherExecutive Officer, DirectorLinked by 6 patents
- Benjamin Peter Behrang ValiExecutive Officer, DirectorNamed in SEC Form D filings
- Chit Peter Behrang LohDirectorNamed in SEC Form D filings
- Farrah Peter Behrang OfnerDirectorNamed in SEC Form D filings
- Keung Wah Ken TangExecutive OfficerNamed in SEC Form D filings
- Lin Hu Hooi OngExecutive Officer, DirectorNamed in SEC Form D filings
Show all 7 people
- William Peter Behrang ClementiDirectorNamed in SEC Form D filings
What it has protected
USPTO · 13 granted of 34- GrantedMETHODS OF CROSSLINKING IgGUSPTOUS 12,673,991
- GrantedProteins That Bind SP17 Including Fully-human ANTI-SP17 AntibodiesUSPTOUS 12,649,790
- GrantedNucleic Acids, Vectors, And Cells That Encode ANTI-SP17 Antibodies And Other SP17 Binding ProteinsUSPTOUS 12,624,097
Show all 34 patent records
- METHODS OF CROSSLINKING IgGJul 7, 2026 · US 12,673,991Granted
- Proteins That Bind SP17 Including Fully-human ANTI-SP17 AntibodiesJun 9, 2026 · US 12,649,790Granted
- Nucleic Acids, Vectors, And Cells That Encode ANTI-SP17 Antibodies And Other SP17 Binding ProteinsMay 12, 2026 · US 12,624,097Granted
- Dimeric AntibodiesMay 5, 2026 · US 12,616,756Granted
- OLIGOMERIC IgG FOR IMMUNOTHERAPEUTICS AND DIAGNOSTICSApr 14, 2026 · US 12,600,795Granted
- Methods Of Enhancing Efficacy Of Immunoconjugates Using Paired Human Antibodies Targeted At Non-overlapping B-cell Epitopes On The Same AntigenJan 1, 2026 · Application 19055378Pending
- Dimeric Immunoconjugates For Use In Treating Cancers And Methods Of UseAug 14, 2025 · Application 18964025Pending
- Proteins That Bind Folate Receptor Alpha Including Fully-human AntibodiesAug 5, 2025 · US 12,378,314Granted
- Methods Of Manufacturing Dimeric AntibodiesJul 29, 2025 · US 12,371,494Granted
- Homodimeric Antibodies For Use In Treating Cancers And Methods Of UseJul 22, 2025 · US 12,364,777Granted
- Dimeric Antibodies And Their Methods Of ManufactureJun 26, 2025 · Application 19002112Pending
- Methods Of Using ANTI-SP17 ImmunotherapeuticsJun 3, 2025 · US 12,319,747Granted
- Methods Of Using Immunotherapeutics That Bind Folate Receptor AlphaMar 25, 2025 · US 12,258,396Granted
- Nucleic Acids, Vectors, And Cells That Encode Antibodies And Other Proteins That Bind Folate Receptor AlphaMar 4, 2025 · US 12,240,900Granted
- Dimeric AntibodiesOct 22, 2024 · US 12,121,587Granted
- Methods Of Manufacturing Dimeric AntibodiesOct 15, 2024 · US 12,116,410Granted
- Dimeric Antibodies And Their Methods Of ManufactureApplication 63614765Pending
- Oligomeric Igg For Immunotherapeutics And DiagnosticsApplication PCTUS2025044378Pending
- Dimeric Immunoconjugates For Use In Treating Cancers And Methods Of UseApplication 63604155Pending
- Methods Of Crosslinking IggApplication PCTUS2025044379Pending
- Methods Of Enhancing Efficacy Of Immunoconjugates Using Paired Human Antibodies Targeted At Non-overlapping B-cell Epitopes On The Same AntigenApplication PCTUS2025036133Pending
- Nucleic Acids, Vectors, And Cells That Encode Antibodies And Other Proteins That Bind Folate Receptor AlphaApplication PCTUS2025014089Pending
- Methods Of Using Immunotherapeutics That Bind Folate Receptor AlphaApplication PCTUS2025014092Pending
- Proteins That Bind Folate Receptor Alpha Including Fully-human AntibodiesApplication PCTUS2025014057Pending
- Dimeric Antibodies And Their Methods Of ManufactureApplication PCTUS2024061935Pending
- Dimeric Immunoconjugates For Use In Treating Cancers And Methods Of UseApplication PCTUS2024057968Pending
- Homodimeric Antibodies For Use In Treating Cancers And Methods Of UseApplication PCTUS2024052137Pending
- Methods Of Manufacturing Dimeric AnitbodiesApplication PCTUS2024045707Pending
- Dimeric AntibodiesApplication PCTUS2024045704Pending
- Proteins That Bind SP17 Including Fully-human ANTI-SP17 AntibodiesApplication PCTUS2024036824Pending
- Methods Of Using ANTI-SP17 ImmunotherapeuticsApplication PCTUS2024036822Pending
- Nucleic Acids, Vectors, And Cells That Encode ANTI-SP17 Antibodies And Other SP17 Binding ProteinsApplication PCTUS2024036820Pending
- Methods Of Enhancing Efficacy Of Immunoconjugates Using Paired Human Antibodies Targeted At Non-overlapping B-cell Epitopes On The Same AntigenApplication 63666523Pending
- Methods Of Enhancing Efficacy Of Immunoconjugates Using Paired Human Antibodies Targeted At Non-overlapping B-cell Epitopes On The Same AntigenApplication 63666595Pending
Related companies, and why
- Starget Pharma Inc.Similar federal contract value in Biotech · null in contracts
- D&D Pharmatech Inc.Similar federal contract value in Biotech · null in contracts
- GPN VACCINES, INC.Similar federal contract value in Biotech · null in contracts
- Bio Usawa Inc.Similar federal contract value in Biotech · null in contracts
- AecorBio Inc.Similar federal contract value in Biotech · null in contracts
- Alcheme Bio Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .